KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Vir Biotechnology (VIR) Non-cash Items (2019 - 2022)

Vir Biotechnology (VIR) has disclosed Non-cash Items for 4 consecutive years, with $52.3 million as the latest value for Q4 2022.

  • Quarterly Non-cash Items fell 70.35% to $52.3 million in Q4 2022 from the year-ago period, while the trailing twelve-month figure was $52.3 million through Dec 2022, down 70.35% year-over-year, with the annual reading at $52.3 million for FY2022, 70.35% down from the prior year.
  • Non-cash Items hit $52.3 million in Q4 2022 for Vir Biotechnology, down from $192.2 million in the prior quarter.
  • In the past five years, Non-cash Items ranged from a high of $290.1 million in Q1 2021 to a low of $16.2 million in Q3 2019.
  • Historically, Non-cash Items has averaged $140.0 million across 4 years, with a median of $142.8 million in 2020.
  • Biggest five-year swings in Non-cash Items: soared 671.5% in 2021 and later tumbled 70.35% in 2022.
  • Year by year, Non-cash Items stood at $55.1 million in 2019, then soared by 98.44% to $109.3 million in 2020, then soared by 61.43% to $176.4 million in 2021, then crashed by 70.35% to $52.3 million in 2022.
  • Business Quant data shows Non-cash Items for VIR at $52.3 million in Q4 2022, $192.2 million in Q1 2022, and $176.4 million in Q4 2021.